
2 companies
argenx
Market Cap: €45.0b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€735.80
7D
-2.3%
1Y
21.7%
Campine
Market Cap: €303.0m
Engages in the circular metals and specialty chemicals businesses in Belgium and internationally.
CAMB
€202.00
7D
12.5%
1Y
69.7%